FDA Approves Botox Competitor That Lasts Longer
FRIDAY, Sept. 9, 2022 (HealthDay News) — People wanting to keep wrinkles at bay will soon have a new option now that the U.S. Food and Drug Administration has approved the first competitor for Botox in decades. Daxxify, made by Revance Therapeutics Inc. in Nashville, Tenn., is injected into theContinue Reading